Welcome Dr. Qing (Vivian) Zhou

Dr. Zhou received her Ph.D. in Pharmacology from Tsinghua University and her M.S. in Biostatistics from Columbia University. Her research focuses on developing novel therapeutic strategies for cancer, with a particular emphasis on glioblastoma.

Her work centers on targeting cancer-related transcriptional programs. She has extensive experience in designing and evaluating approaches to modulate transcription factor activity, and in assessing their efficacy across multiple cancer models, including both in vitro systems and preclinical animal models, as monotherapies and in combination with other treatments. Her research also investigates the molecular mechanisms underlying therapeutic response and resistance, with a focus on transcriptional regulation, metabolic reprogramming, tumor–immune interactions, and DNA damage response pathways, integrating both experimental and computational approaches.

In the context of glioblastoma, Dr. Zhou is interested in tumor–microenvironment interactions, and how these interactions influence tumor progression and therapeutic resistance. Her work places particular emphasis on tumor–immune dynamics and their role in shaping therapeutic response. By integrating therapeutic development with insights into the tumor microenvironment, she aims to identify and validate new strategies to inhibit tumor growth and overcome resistance.

Dr. Zhou’s long-term goal is to advance the understanding of cancer biology and translate promising therapeutic approaches into clinically relevant treatments for patients with glioblastoma and other malignancies.